EBSEmergent BioSolutions Inc.
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationall…
Industry Peers
Drug Manufacturers - Specialty & Generic| Headline | Source | Time |
|---|---|---|
Older | ||
 Emergent BioSolutions (EBS) Q2 2026 Earnings Call Transcript MCM deliveries surge but naloxone competition forces restructuring and guidance cuts. | ||
 Why Did TTD, PZZA, EBS Stocks Plummet To 52 Week Lows? Shares of Trade Desk, Papa John’s International, Emergent Biosolutions declined after the companies posted disappointing Q2 results last week. | ||
 Emergent Biosolutions Q2 Earnings Call Highlights Emergent Biosolutions (NYSE:EBS) reported second-quarter 2026 revenue and adjusted EBITDA above its prior guidance and analyst consensus, driven by accelerated medical countermeasure deliveries to U.S. government customers. The company also lowered its full-year outlook as increased competition and | ||
 Emergent BioSolutions Inc. Q2 2026 Earnings Call Summary Moby summary of Emergent BioSolutions Inc.'s Q2 2026 earnings call | ||